NATIONAL PSORIASIS FOUNDATION for NATIONAL PSORIASIS FOUNDATION
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 2077 - Restoring the Patient's Voice Act; HR 2999 Patients' Access to Treatment Act; S 1113 - Personal Care Products Safety Act; Patient Access Issues; NIH/Health Research Funding;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA NAGRO New | — |
| PATRICK STONE New | — |
Medicare/Medicaid MMM
HR 2077 - Restoring the Patient's Voice Act; HR 2999 Patients' Access to Treatment Act; S 1113 - Personal Care Products Safety Act; Patient Access Issues; NIH/Health Research Funding;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA NAGRO New | — |
| PATRICK STONE New | — |
Pharmacy PHA
HR 2077 - Restoring the Patient's Voice Act; HR 2999 Patients' Access to Treatment Act; S 1113 - Personal Care Products Safety Act; Patient Access Issues; NIH/Health Research Funding;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA NAGRO New | — |
| PATRICK STONE New | — |
Medical/Disease Research/Clinical Labs MED
HR 2077 - Restoring the Patient's Voice Act; HR 2999 Patients' Access to Treatment Act; S 1113 - Personal Care Products Safety Act; Patient Access Issues; NIH/Health Research Funding;
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA NAGRO New | — |
| PATRICK STONE New | — |
Affiliated organisations
| Organisation | Location |
|---|---|
| FAEGRE BAKER DANIELS | Washington, DC, US |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.